Regeneron Pharmaceuticals, INC.: 13F Holdings & AI Insights

Name: Regeneron Pharmaceuticals, INC. — 13F Holdings, 2026-03-31
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0000872589

Concentrated strategyQuality / disciplined sizing

Total reported value

$47.9M

Reporting period: 2026-03-31 · Number of holdings: 2

REGENERON PHARMACEUTICALS, INC. disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $47.9M and a quarterly turnover rate of 35.0%.

Browse other institutions with under $100M AUM Browse other institutions starting with "R"

Personality snowflake

Concentration: 100
Portfolio Stability: 34.96
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 4
Sizing Uniformity: 86.1

Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/regeneron-pharmaceuticals-inc

Recent moves

Add NTLA
0.0%　$14.2M
Trim TORCEUR
0.0%　-$97.4K

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	NTLA	Intellia Therapeutics INC	Stock-Other	99.14%	+0.65%	—
2	TORCEUR	Adicet Bio INC	Stock-Other	0.86%	-0.65%	—

Portfolio Performance

Performance for Q3 2026

-15.6%

Performance Last 4 Quarters

-26.7%

Stdev: +45.3%
Beta: +0.86
Alpha: +5.2%
Max Drawdown: -37.4%
Annualized Perf: +10.7%
Batting Avg vs S&P: +35.3%
Sortino: +0.66
Stutzer: +0.13
Treynor: +0.24
Sterling: +0.22
Calmar: +0.29
Information Ratio: +0.06
Tracking Error: +43.8%
Stdev Down: +31.3%
Winning Months %: +52.9%
Losing Months %: +47.1%
Best 12 Months: +39.8%
Worst 12 Months: -26.7%
Efficiency Ratio: +0.09
Sharpe: +0.46
Stdev Sectors: —
Skewness: -0.84
Kurtosis: +1.01
Upside Potential: +2.19

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	2	$47.9M	35	1NTLA 2TORCEUR Top holdings2026-03-31 1.NTLA 2.TORCEUR
2025-12-31	2	$33.8M	100	1NTLA 2TORCEUR Top holdings2025-12-31 1.NTLA 2.TORCEUR
2025-09-30	4	$700.4M	56	1ALNY 2NTLA 3AVU0 Top holdings2025-09-30 1.ALNY 2.NTLA 3.AVU0 4.TORCEUR
2025-06-30	4	$1.5B	0	1ALNY 2NTLA 3TORCEUR Top holdings2025-06-30 1.ALNY 2.NTLA 3.TORCEUR 4.AVU0
2025-03-31	6	$1.2B	0	1ALNY 2NTLA 3TSVT* Top holdings2025-03-31 1.ALNY 2.NTLA 3.TSVT* 4.AVU0 5.TORCEUR 6.BLE0
2024-12-31	6	$1.1B	0	1ALNY 2NTLA 3TSVT* Top holdings2024-12-31 1.ALNY 2.NTLA 3.TSVT* 4.TORCEUR 5.AVU0 6.BLE0

Holding changes this quarter

Position changes disclosed by Regeneron Pharmaceuticals, INC. for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	NTLA	Intellia Therapeutics INC	+0.7%	—	Unchanged
2	TORCEUR	Adicet Bio INC	-0.7%	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2026-03-31	2026-05-08	13F-HR	View on EDGAR
2025-12-31	2026-02-06	13F-HR	View on EDGAR
2025-09-30	2025-11-07	13F-HR	View on EDGAR
2025-06-30	2025-08-01	13F-HR	View on EDGAR
2025-03-31	2025-05-02	13F-HR	View on EDGAR
2024-12-31	2025-02-07	13F-HR	View on EDGAR

FAQ

What is Regeneron Pharmaceuticals, INC. and what type of investor is it?

Regeneron Pharmaceuticals, INC. is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $47.9M, spread across 2 disclosed positions.

What are Regeneron Pharmaceuticals, INC.'s largest equity positions?

Based on the latest 13F filing, Regeneron Pharmaceuticals, INC.'s top holdings by market value are: 1. Intellia Therapeutics INC (NTLA) — $47.5M (99.1%) 2. Adicet Bio INC (TORCEUR) — $412.1K (0.9%)

What changes did Regeneron Pharmaceuticals, INC. make in its most recent portfolio filing?

No notable portfolio changes were recorded for Regeneron Pharmaceuticals, INC. in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Regeneron Pharmaceuticals, INC. focus on?

Sector breakdown data is not yet available for Regeneron Pharmaceuticals, INC.. Check back after the next 13F processing cycle.

Peer Institutions

Institutions with a similar AUM

Fithian, LLC

CIK 0001965962

Total reported value

$47.9M

17 stks

2023-03-31

Stale — no recent filing

Concentration46.8

Portfolio Stability0.0

Sector conviction100.0

AUM within 0.1% of this institution

View detail

CTC Capital Management, LLC

CIK 0001910419

Total reported value

$47.8M

72 stks

2023-03-31

Stale — no recent filing

Concentration52.4

Portfolio Stability0.0

Sector conviction58.4

AUM within 0.2% of this institution

View detail

DCM International V, Ltd

CIK 0001440813

Total reported value

$47.8M

1 stks

2018-09-30

Stale — no recent filing

Concentration100.0

Portfolio Stability16.5

Sector conviction0.0

AUM within 0.3% of this institution

View detail

Developer Access

Access Regeneron Pharmaceuticals, INC.'s institutional profile programmatically:

REST API

curl https://alphasmo.com/api/v1/institutions/regeneron-pharmaceuticals-inc

CLI

npx alphasmo institutions get regeneron-pharmaceuticals-inc

Full API & MCP documentation →

Personality snowflake

Concentration

100

Portfolio Stability

34.96

Momentum/Contrarian

Sector conviction

Diversification

Sizing Uniformity

86.1

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/regeneron-pharmaceuticals-inc

Ticker

Issuer

Asset Subclass

Weight

Weight Change

Shares Change

4Q Trend

NTLA

Intellia Therapeutics INC

Stock-Other

99.14%

+0.65%

—

TORCEUR

Adicet Bio INC

Stock-Other

0.86%

-0.65%

—

Portfolio Performance

Performance for Q3 2026

-15.6%

Performance Last 4 Quarters

-26.7%

Stdev: +45.3%
Beta: +0.86
Alpha: +5.2%
Max Drawdown: -37.4%
Annualized Perf: +10.7%
Batting Avg vs S&P: +35.3%
Sortino: +0.66
Stutzer: +0.13
Treynor: +0.24
Sterling: +0.22
Calmar: +0.29
Information Ratio: +0.06
Tracking Error: +43.8%
Stdev Down: +31.3%
Winning Months %: +52.9%
Losing Months %: +47.1%
Best 12 Months: +39.8%
Worst 12 Months: -26.7%
Efficiency Ratio: +0.09
Sharpe: +0.46
Stdev Sectors: —
Skewness: -0.84
Kurtosis: +1.01
Upside Potential: +2.19

Period

Holdings

Total value

Stability

Top holdings

2026-03-31

$47.9M

1NTLA 2TORCEUR

2025-12-31

$33.8M

100

$700.4M

$1.5B

$1.2B

$1.1B

Ticker

Issuer

Weight Change

Shares Change

Action

NTLA

Intellia Therapeutics INC

+0.7%

—

Unchanged

TORCEUR

Adicet Bio INC

-0.7%

—

Unchanged

Period

Filed

Type

EDGAR

2026-03-31

2026-05-08

13F-HR

View on EDGAR

2025-12-31

2026-02-06

13F-HR

View on EDGAR

2025-09-30

2025-11-07

13F-HR

View on EDGAR

2025-06-30

2025-08-01

13F-HR

View on EDGAR

2025-03-31

2025-05-02

13F-HR

View on EDGAR

2024-12-31

2025-02-07

13F-HR

View on EDGAR

FAQ

What is Regeneron Pharmaceuticals, INC. and what type of investor is it?

What are Regeneron Pharmaceuticals, INC.'s largest equity positions?

What changes did Regeneron Pharmaceuticals, INC. make in its most recent portfolio filing?

No notable portfolio changes were recorded for Regeneron Pharmaceuticals, INC. in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Regeneron Pharmaceuticals, INC. focus on?

Sector breakdown data is not yet available for Regeneron Pharmaceuticals, INC.. Check back after the next 13F processing cycle.